• 360 Citations
  • 7 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Luis Mas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Latin America Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Anemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 360 Citations
  • 7 h-Index
  • 11 Article
  • 3 Review article
2 Citations (Scopus)

ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer

Rosas, G., Ruiz, R., Araujo, J. M., Pinto, J. A. & Mas, L., Apr 1 2019, In : Critical Reviews in Oncology/Hematology. 136, p. 48-55 8 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Genes
Routine Diagnostic Tests
Epidemiology
Therapeutics
1 Citation (Scopus)

Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP)

on behalf CLICaP, Mar 1 2019, In : Thoracic Cancer. 10, 3, p. 508-518 11 p.

Research output: Contribution to journalArticle

Open Access
Latin America
Mesothelioma
Drug Therapy
Survival
Pemetrexed
1 Citation (Scopus)

Anemia como factor pronóstico en pacientes con cáncer

Translated title of the contribution: Anemia as a prognostic factor in cancer patientsPaitan Amaro, V. R., Alcarraz, C., Leonardo, A., Valencia, G., Mantilla, R., Morante, Z., Oscanoa, T. J. & Mas, L., Apr 1 2018, In : Revista Peruana de Medicina Experimental y Salud Publica. 35, 2, p. 250-258 9 p.

Research output: Contribution to journalArticle

Anemia
Hematologic Neoplasms
Neoplasms
Urologic Neoplasms
Gastrointestinal Neoplasms

Citorreducción óptima en cáncer de ovario avanzado tratado con paclitaxel a dosis densa y carboplatino seguido de cirugía de intervalo en el instituto nacional de enfermedades neoplásicas del Perú

Translated title of the contribution: Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the Peruvian national institute of neoplastic diseasesAlcarraz Molina, C., Muñiz, J., Mas, L., Olivera, M., Morante, Z., Alvarez, M., Mantilla, R., Araujo, J. & Pinto, J., Jan 1 2018, In : Revista Peruana de Medicina Experimental y Salud Publica. 35, 1, p. 46-54 9 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Ovarian Neoplasms
Carcinoembryonic Antigen
Disease-Free Survival
9 Citations (Scopus)

The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments

Raez, L. E., Cardona, A. F., Santos, E. S., Catoe, H., Rolfo, C., Lopes, G., Barrios, C., Mas, L., Vallejos, C. S., Zatarain-Barrón, Z. L., Caglevic, C. & Arrieta, O., May 1 2018, In : Lung Cancer. 119, p. 7-13 7 p.

Research output: Contribution to journalReview article

Latin America
Immunotherapy
Lung Neoplasms
Smoking
Tobacco Use Cessation